|
argenx SE (ARGX) DCF Valuation
NL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
argenx SE (ARGX) Bundle
Simplify argenx SE (ARGX) valuation with this customizable DCF Calculator! Featuring real argenx SE (ARGX) financials and adjustable forecast inputs, you can test scenarios and uncover argenx SE (ARGX) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81.4 | 46.8 | 518.4 | 428.2 | 1,278.3 | 1,725.8 | 2,329.9 | 3,145.4 | 4,246.4 | 5,732.7 |
| Revenue Growth, % | 0 | -42.59 | 1008.8 | -17.4 | 198.56 | 35 | 35 | 35 | 35 | 35 |
| EBITDA | -185.2 | -627.2 | -327.8 | -606.7 | -225.2 | -1,314.5 | -1,774.6 | -2,395.8 | -3,234.4 | -4,366.6 |
| EBITDA, % | -227.48 | -1341.56 | -63.23 | -141.7 | -17.62 | -76.17 | -76.17 | -76.17 | -76.17 | -76.17 |
| Depreciation | 2.5 | 4.4 | 6.1 | 108.8 | 116.2 | 166.3 | 224.6 | 303.2 | 409.3 | 552.5 |
| Depreciation, % | 3.1 | 9.41 | 1.18 | 25.4 | 9.09 | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
| EBIT | -187.8 | -631.6 | -333.9 | -715.5 | -341.4 | -1,350.0 | -1,822.5 | -2,460.4 | -3,321.6 | -4,484.3 |
| EBIT, % | -230.58 | -1350.98 | -64.41 | -167.1 | -26.71 | -78.22 | -78.22 | -78.22 | -78.22 | -78.22 |
| Total Cash | 1,558.8 | 2,088.2 | 2,435.9 | 2,285.6 | 3,314.8 | 1,725.8 | 2,329.9 | 3,145.4 | 4,246.4 | 5,732.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 23.6 | .2 | 34.1 | 289.0 | 520.5 | 497.9 | 672.2 | 907.5 | 1,225.1 | 1,653.9 |
| Account Receivables, % | 28.93 | 0.5244 | 6.58 | 67.51 | 40.71 | 28.85 | 28.85 | 28.85 | 28.85 | 28.85 |
| Inventories | -1,065.7 | 26.4 | 113.7 | 238.0 | 323.7 | 204.4 | 276.0 | 372.5 | 503.0 | 679.0 |
| Inventories, % | -1308.71 | 56.37 | 21.93 | 55.59 | 25.32 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 |
| Accounts Payable | 68.4 | 215.3 | 217.7 | 196.7 | 256.0 | 1,007.7 | 1,360.4 | 1,836.5 | 2,479.4 | 3,347.2 |
| Accounts Payable, % | 83.97 | 460.54 | 42 | 45.95 | 20.02 | 58.39 | 58.39 | 58.39 | 58.39 | 58.39 |
| Capital Expenditure | -48.7 | -5.7 | -126.6 | -108.2 | -45.7 | -432.5 | -583.9 | -788.3 | -1,064.3 | -1,436.8 |
| Capital Expenditure, % | -59.82 | -12.22 | -24.42 | -25.28 | -3.57 | -25.06 | -25.06 | -25.06 | -25.06 | -25.06 |
| Tax Rate, % | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 |
| EBITAT | -193.4 | -634.9 | -341.0 | -696.1 | -330.8 | -1,334.3 | -1,801.3 | -2,431.9 | -3,283.1 | -4,432.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 870.9 | -1,558.0 | -580.3 | -1,095.8 | -518.1 | -706.9 | -2,053.8 | -2,772.7 | -3,743.3 | -5,053.5 |
| WACC, % | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -11,680.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -5,155 | |||||||||
| Terminal Value | -138,956 | |||||||||
| Present Terminal Value | -105,271 | |||||||||
| Enterprise Value | -116,951 | |||||||||
| Net Debt | -2,115 | |||||||||
| Equity Value | -114,836 | |||||||||
| Diluted Shares Outstanding, MM | 57 | |||||||||
| Equity Value Per Share | -2,008.70 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Argenx SE’s financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model that caters to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life ARGX Financials: Pre-filled historical and projected data for argenx SE (ARGX).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate argenx’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize argenx’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file containing argenx SE's (ARGX) financial data.
- 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to enhance your decision-making process.
Why Choose This Calculator for argenx SE (ARGX)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses all in one easy-to-use platform.
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes argenx SE’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on argenx SE (ARGX).
Who Should Use This Product?
- Investors: Evaluate argenx SE’s (ARGX) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Optimize valuation workflows and assess financial forecasts.
- Startup Founders: Understand the valuation methods applied to biotech firms like argenx SE.
- Consultants: Provide clients with comprehensive valuation analyses for informed decision-making.
- Students and Educators: Utilize current data to practice and instruct on valuation methodologies.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled argenx SE (ARGX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for argenx SE (ARGX).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.